Jockers-Scherübl et al. (73, 74) found significantly higher concentrations of neurotrophins [nerve growth factor (NGF) and brain-derived neurotrophic factor (BDNF)] in schizophrenia patients with previous CU, compared to non-using schizophrenia patients. This evidence concerns the gene NGF and schizophrenia.